CytoSorb: Biocon gets DCGI nod for CytoSorb use in critical Covid-19 cases – Times of India

BENGALURU: Biocon said its subsidiary Biocon Biologics has received the Drugs Controller General of India’s (DCGI) approval for an extracorporeal blood purification (EBP) device CytoSorb to reduce pro- inflammatory cytokines levels in confirmed ovid-19 patients admitted to ICU with confirmed or imminent respiratory failure. Biocon Biologics has been granted licence for emergency use of CytoSorb…

Details

South Korea Coronavirus: World watches as South Korea cautiously returns to life | World News – Times of India

SEOUL: The baseball league is on. Students have begun returning to school. And people are increasingly dining out and enjoying nighttime strolls in public parks. As South Korea significantly relaxes its rigid social distancing rules as a result of waning coronavirus cases, the world is paying close attention to whether it can return to something…

Details